Sanofi Profit Drops on Generics, Pandemic Flu End

generic competition dented sales of five key medicines and the end of the pandemic wiped out demand for swine flu vaccines. Earnings slid to 2.17 billion euros ($3.23 billion), or 1.66 euros a share, excluding costs such as writedowns and merger...